Citation Impact
Citing Papers
Realist review - a new method of systematic review designed for complex policy interventions
2005 Standout
A collaborative research model in family practice.
1974
Partial Response and Nonresponse to Antidepressant Therapy
2002
Gender variations in clinical pain experience
1996 Standout
The improved Clinical Global Impression Scale (iCGI): development and validation in depression
2007
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
Twelve-Month Use of Mental Health Services in the United States
2005 Standout
Childhood and Adolescent Depression: A Review of the Past 10 Years. Part I
1996 Standout
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings
1997
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
2009
Neuroleptic Withdrawal in Schizophrenic Patients
1995
Cognitive deficits as treatment targets in schizophrenia
2004
Association between atypical antipsychotic agents and type 2 diabetes: Review of prospective clinical data
2004
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
2007 Standout
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2006 Standout
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Microbiota and SCFA in Lean and Overweight Healthy Subjects
2009 Standout
Translating Research Into Practice: The Schizophrenia Patient Outcomes Research Team (PORT) Treatment Recommendations
1998
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder
2003 Standout
Clinical predictors of relapse following neuroleptic withdrawal
1992
The psychopathology, medical management and dental implications of schizophrenia
2002
Optimal Dosing of Atypical Antipsychotics in Adults: A Review of the Current Evidence
2002
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues
2002
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
2004
Use of Antipsychotics in the Management of Schizophrenia during Pregnancy
2005
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
2010 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Biodegradable polymeric nanoparticles based drug delivery systems
2009 Standout
Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia
2002 Standout
Measuring the Quality of Outpatient Treatment for Schizophrenia
1998
Physicians and the Pharmaceutical Industry
2000 Standout
Diazepam Treatment of Early Signs of Exacerbation in Schizophrenia
1999
Use and Safety of Antipsychotic Drugs During Pregnancy
2009
Baseline and 2− to 3-Year Follow-up Characteristics of Placebo-Washout Responders from the Nortriptyline Study of Depressed 6− to 12-Year-Olds
1992
Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia
2001
How stigma interferes with mental health care.
2004 Standout
Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain
2004
Is interval medication a successful treatment regimen for schizophrenic patients with critical attitudes towards treatment?⋆
2003
IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION
2007 StandoutNobel
Second-Generation (Atypical) Antipsychotics and Metabolic Effects
2005
Family intervention for schizophrenia
2006
Savoxepine versus haloperidol
2002
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Maintenance therapies for classic and other forms of bipolar disorder
2000
Randomized controlled trials in schizophrenia: a critical perspective on the literature
2002
The clinical global impressions scale: applying a research tool in clinical practice.
2007 Standout
Tardive Dyskinesia: Reversible and Irreversible
1985
Effects of Psychopharmacologic Agents on Learning Disorders
1973
Illicit Drug Use and Addiction in the United States: Review of Available Statistics
1970
Symptomatic volunteers in psychiatric research
1971
Cortical inhibitory neurons and schizophrenia
2005 Standout
Interventions for enhancing medication adherence
2008 Standout
Sex differences in the content and style of medical advertisements
1975
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia
2005
Review of literature on the factors affecting drug prescribing
1975
The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale
1976 Standout
Culture, Illness, and Care
1978 Standout
An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings
1994
The prevalence of knee osteoarthritis in the elderly. the framingham osteoarthritis study
1987 Standout
Helping clients forgive: An empirical guide for resolving anger and restoring hope.
2000 Standout
Interventions for enhancing medication adherence
2014 Standout
Neuroleptic Dosing and Neuroleptic Plasma Levels in Schizophrenia: Determining the Optimal Regimen
1995
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Précis ofThe neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system
1982 Standout
Drug use among adolescents and their parents: Closing the generation gap in mood modification.
1972
THE FUTURE OF PSYCHIATRY
1973
Sex, illness, and medical care
1977
Sex Differences and the Epidemiology of Depression
1977 Standout
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
1987 Standout
New developments in the pharmacologic treatment of schizophrenia
1993
National Patterns of Psychotherapeutic Drug Use
1973
Tardive Dyskinesia: Barriers to the Professional Recognition of an Iatrogenic Disease
1986
Gender and Health: An Update on Hypotheses and Evidence
1985 Standout
Inositol for depressive disorders
2004
Normative data on Revised Conners Parent and Teacher Rating Scales
1978 Standout
The Metabolic Effects of Antipsychotic Medications
2006
Naming and Framing: The Social Construction of Diagnosis and Illness
1995 Standout
Hallucinogens
2004 Standout
Drug Use: Demography and Attitudes in a Junior and Senior High School Population
1974 StandoutNobel
Symptomatic Volunteers: Another Patient Dimension for Clinical Trials
1973
Works of J Levine being referenced
Conventional Antipsychotic Medications for Schizophrenia
1995
P.2.063 Antipsychotic medication treatment and new prescriptions for insulin and oral hypoglycemics
2003
Inositol treatment in psychiatry.
1995
Utilization of depot neuroleptic medication in psychiatric inpatients.
1996
Research and methodological issues for evaluating the therapeutic effectiveness of antidepressant drugs.
1984
Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
1980
Continuous versus targeted medication in schizophrenic outpatients: outcome results [published erratum appears in Am J Psychiatry 1991 Jun;148(6):819]
1990
The nature and extent of psychotropic drug usage in the United States.
1969